Age Related Macular Degeneration Market – Industry Size, Share, Trends, Segments, Efficiency, Competitive Landscape and Key Countries Analysis to 2023
Global Age-Related Macular Degeneration Market Research Report Covers Historical Market Trends, Current Market Dynamics, Market Valuation by Segmentation as Well as Region, Country-level Analysis for Every Segment, Key Player’s Market Share Analysis, Competitive Landscape and Supply Chain Analysis.
Age Related Macular Degeneration Market Research Report 2019: Industry Size, Share, Trends, Growth and Opportunity Assessment, Regional Analysis and Segmentation By Type (Wet AMD & Dry AMD), by Stages (Intermediate AMD, Early AMD, & Late AMD), by Age Group (Above 75, Above 60, & Above 40), by Diagnosis & Treatment, and End-User – Global Forecast Till 2023
The main trends have created a positive tone for market’s development. By safeguarding supply and demand, the competitors can capture new opportunities for growth. Santen Pharmaceuticals, F. Hoffmann-La Roche AG, Novartis AG, Bayer AG, Regeneron Pharmaceutical Inc., and others are a few of the significant competitors in this market.
Get a FREE Sample with Complete TOC @ https://www.marketresearchfuture.com/sample_request/5736
The high incidence rate of age-related macular degeneration has been observed because of a substantial uptick in global geriatric population. The disease causes significant loss of central vision and is also commonly referenced to as the cause for blindness. With the advancement of age, a rise in pleomorphism because of retinal pigment epithelial cells is witnessed along with a decrease in the concentration of cells in the posterior pole, and drop of melanin content in the eyes which causes macular degeneration.
The market is foreseen to reach USD 2214.82 million in revenue, exhibiting an 8.3 percent CAGR approximately in the forecast period by 2023. Mounting geriatric population, escalating prevalence of age-related macular degeneration and a few of the best-selling drugs going off-patent are the chief factors fuelling the development of the market across the globe. Frequency and commonness of the condition is expected to intensify as the population ages get more varied in the forthcoming period. Early AMD symptoms have been found in young adults under the age of 30 years by specific studies into the condition. Lifestyle and metabolic factors are among the common factors attributed to the increase in the cases of age-related macular degeneration outside of the established age group.
The older adults segment is considerably boosting the progress of the market as it pushes the demand for new, and advanced therapeutic and diagnostic products of higher accuracy further. The patent of some popular branded drugs expiring in the coming years will encourage other manufacturers to introduce drugs of higher efficacy, thereby increasing market share substantially. Furthermore, the increase of new drugs being launched in the market will enhance the age-related macular degeneration market shortly.
- Medical Devices Companies
- Research and Development (R&D) Companies
- Pharmaceutical Companies
- Government Research Institutes
- Academic Institutes and Universities
The age-related macular degeneration market is segmented on the basis of route of administration, type, age group, diagnosis & treatment, end-user, and stages. The route of administration basis of segmentation of the market comprises of intravenous, intravitreal, and others. The basis of segmentation on types consists of dry age-related macular degeneration (dry AMD)/non-neovascular and wet age-related macular degeneration (wet AMD)/neovascular. On the basis of age group, the market segmentation includes >40 years, >75 years and >60 years. The diagnosis & treatment basis of market segmentation consists of dry AMD treatment and wet AMD treatment. The wet AMD Treatment market comprises of laser surgery, photodynamic therapy, anti-vascular endothelial growth factor (VEGF), among others. The dry AMD Treatment market consists of telescopic lens implant and nutrition therapy. The diagnosis market is segmented into fluorescein angiogram, optical coherence tomography, preliminary test, and others. The end user segment of the market comprises of diagnostic centers, hospitals & clinics, academic research institutes, and others. On the basis of stages, segmentation of the market includes early age-related macular degeneration (AMD), Intermediate age-related macular degeneration (AMD), and late age-related macular degeneration (AMD).
Detailed Regional Analysis
The region-based analysis of the market covers Americas, Europe, Middle East, Asia Pacific and Africa. The Americas region is projected to dominate the global age-related macular degeneration market owing to the mounting level of ophthalmological disorders and growth in the aging population. Furthermore, the growing government initiatives and financial backing are motivating the advance of age-related macular degeneration market in the North America region. The European region holds the second important market due to the expanding demand for technologically innovative treatments which are fuelling the development of age-related macular degeneration market in the European region. The Asia Pacific is a swiftly growing market for the age-related macular degeneration as it is developing at a very speedy pace and is also graced with the appearance of many competitors. Furthermore, the intensifying occurrences of eye disorders, growing healthcare expenditure and the entry of multinational companies in developing economies to establish operational set-ups are likely to motivate the growth of the market. Additionally, India and China are the chief backers to the market’s development because of the rapid development of the healthcare infrastructure in these regions and growing demand for better healthcare services.
The Objective of the study:
- To provide a comprehensive analysis of the market scenario along with forecast of the various segments and sub-segments of the AMD market.
- To understand the historical growth of the market and forecast market revenue for the next five years.
- To provide country level analysis of the market with respect to the current market size and future prospective across North America, Europe, South America, the Middle East & Africa (MEA), Asia Pacific (APAC).
- To profile some of the top players operating in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
- The study offers a detailed market revenue estimation by analyzing; it on the basis of disease type, stages, age group, diagnosis & treatment, route of administration and end-user
Early Diners Are Offered Free Customization- Up to 20%
Get More Information on Age Related Macular Degeneration Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/age-related-macular-degeneration-market-5736
List of Tables
Table 1 Age-related Macular Degeneration Industry Synopsis, 2017–2023
Table 2 Age-related Macular Degeneration Market Estimates & Forecast, 2017–2023, (Usd Million)
Table 3 Age-related Macular Degeneration Market, by Region, 2017–2023, (Usd Million)
Table 4 Age-related Macular Degeneration Market, by Type, 2017–2023, (Usd Million)
Table 5 Age-related Macular Degeneration Market, by Drug, 2017–2023, (Usd Million)
Table 6 Age-related Macular Degeneration Market, by Route of Administration, 2017–2023, (Usd Million)
Table 7 Age-related Macular Degeneration Market, by Treatment, 2017–2023, (Usd Million)
Table 8 Age-related Macular Degeneration Market, by End-user, 2017–2023, (Usd Million)
Table 9 North America Age-related Macular Degeneration Market, by Type, 2017–2023, (Usd Million)
Table 10 North America Age-related Macular Degeneration Market, by Drug, 2017–2023, (Usd Million)
List of Figures
Figure 1 Research Process
Figure 2 Segmentation for Age-related Macular Degeneration Market
Figure 3 Segmentation Market Dynamics for Age-related Macular Degeneration Market
Figure 4 Global Age-related Macular Degeneration Market Share, by Type 2016
Figure 5 Global Age-related Macular Degeneration Market Share, by Drug 2016
Figure 6 Global Age-related Macular Degeneration Market Share, by Route of Administration, 2016
Figure 8 Global Age-related Macular Degeneration Market Share, by Treatment, 2016
Figure 9 Global Age-related Macular Degeneration Market Share, by End-user, 2016
Figure 10 Global Age-related Macular Degeneration Market Share, by Region, 2016
Ask for your specific company profile and country level customization on reports.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.